Business
Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives
By Meg Flippin Benzinga Glucotrack will host a virtual webinar discussing its Continuous Blood Glucose Monitor (CBGM) innovation on May 29 at 11 am ET. The
About this update from Glucotrack, Inc.
[{"type":"text","content":"By Meg Flippin Benzinga\n Glucotrack will host a virtual webinar discussing its Continuous Blood Glucose Monitor (CBGM) innovation on May 29 at 11 am ET.\n\n The current diabetes management tools for glucose monitoring are cumbersome and a relentless reminder of the disease.\n\n Glucotrack executives will explain how its technology works, provide an update on its clinical trial and give an overview of the future of diabetes management.\n\n \n DETROIT, MICHIGAN - May 29, 2025 (NEWMEDIAWIRE) - Glucotrack Inc. (NASDAQ: GCTK) will host a virtual webinar on Thursday, May 29, from 11 a.m. to 12 p.m. ET to discuss its Continuous Blood Glucose Monitor (CBGM) technology, a potentially game-changing medical device that could reshape how diabetes is managed.\n Experts from the Rutherford, New Jersey medical technology company will lead the session, providing a deep dive into how CBGM technology works and how it can transform the lives of people suffering from diabetes. Glucotrack experts will also discuss the critical role real-time continuous blood glucose tracking can play and why diabetes patients need a new, innovative solution.\nThe Existing Tools Are Too Cumbersome\nWhen it comes to managing diabetes, historically the main way of tracking a person's sugar in their blood has been via a glucose meter, which requires the person to prick his or her finger several times a day to get a sample of the blood. The results are generally accurate, granted it is stored properly and the patient remembers to test often.\nContinuous glucose monitoring (CGM) offers a less intrusive alternative. With it, a person's blood glucose level is monitored automatically through a device 24 hours a day. It enables the diabetes patient to review their blood glucose level in real time to make well-informed decisions and adjust behavior on the spot. \nGlucotrack's Different Approach\nWhen it comes to CGMs, not all devices are created equally. The duration for which the monitoring lasts, the placement of the device and how often data is received differ from one manufacturer to the next. Plus, the sensors and implantables on the market need to be reapplied or recalibrated every ten to 90 days. \nGlucotrack is different. Glucotrack's implantable CBGM measures glucose in the blood, without the lag time associated with subcutaneous sensors that measure glucose in inter...